MD Stem Cells
www.mdstemcells.comMD Stem Cells is the sponsor of Institutional Review Board (IRB) approved, National Institutes of Health (NIH) registered studies using autologous (from the same patient) Bone Marrow Derived Stem Cells (BMSC). Current studies encompass Ophthalmology, Neurology and Spinal Cord Injury/ Paraplegia. For detailed information please visit our website www.mdstemcells.com MD Stem Cells publishes extensively in peer-reviewed, high quality medical and scientific publications. MD Stem Cells provides the only available, proven treatment using BMSC for Non-arteritic ischemic optic neuropathy (NAION) also called a stroke of the optic nerve. We provide the only available, proven treatment for Retinitis Pigmentosa (RP). Both have proven findings that are statistically significant. Please see www.mdstemcells.com for details.
Read moreMD Stem Cells is the sponsor of Institutional Review Board (IRB) approved, National Institutes of Health (NIH) registered studies using autologous (from the same patient) Bone Marrow Derived Stem Cells (BMSC). Current studies encompass Ophthalmology, Neurology and Spinal Cord Injury/ Paraplegia. For detailed information please visit our website www.mdstemcells.com MD Stem Cells publishes extensively in peer-reviewed, high quality medical and scientific publications. MD Stem Cells provides the only available, proven treatment using BMSC for Non-arteritic ischemic optic neuropathy (NAION) also called a stroke of the optic nerve. We provide the only available, proven treatment for Retinitis Pigmentosa (RP). Both have proven findings that are statistically significant. Please see www.mdstemcells.com for details.
Read moreCountry
State
Connecticut
City (Headquarters)
Westport
Industry
Employees
1-10
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Founder and Chief Executive Officer of Stem Cells America , Inc.
Email ****** @****.comPhone (***) ****-****Convener
Email ****** @****.comPhone (***) ****-****
Technologies
(23)